A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease [0.03%]
阻塞性睡眠呼吸暂停与代谢相关性脂肪性肝病的双向关联关系
Anish Preshy,James Brown
Anish Preshy
Obesity is considered a twentieth-century epidemic and is a growing concern among health professionals. Obesity and its complications contribute to multiple chronic illnesses, such as type 2 diabetes (T2D), metabolic syndrome, obstructive s...
Triada Bali,Lampros Chrysavgis,Evangelos Cholongitas
Triada Bali
The current evidence indicates a strong association between sarcopenia, the loss of muscle mass and strength, and metabolic-associated fatty liver disease (MAFLD). The two entities share many common pathophysiologic mechanisms, and their co...
Thomas M Barber,Petra Hanson,Martin O Weickert
Thomas M Barber
As an important sequela of the burgeoning global obesity problem, metabolic-associated fatty liver disease (MAFLD) has gained increasing prominence recently. The gut-liver axis (GLA) provides a direct conduit to the liver for the gut microb...
Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy [0.03%]
与糖尿病相关的代谢相关性脂肪肝病：双重打击
Nitin Kapoor,Sanjay Kalra
Nitin Kapoor
Metabolic-associated fatty liver disease (MAFLD) is the hepatic manifestation of metabolic syndrome and affects about 55% of people living with diabetes. MAFLD has been shown to be an individual risk factor for cardiovascular disease and it...
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease [0.03%]
代谢紊乱相关非酒精性脂肪性肝病的心血管影响
Zhewen Ren,Anke Wesselius,Coen D A Stehouwer et al.
Zhewen Ren et al.
Both nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) have been associated with incident cardiovascular disease (CVD), independent of confounders. Causality has recently been inferred...
Shima Dowla Anwar,Christy Foster,Ambika Ashraf
Shima Dowla Anwar
Dyslipidemia has been linked metabolic-associated fatty liver disease (MAFLD). Several genes and transcription factors involved in lipid metabolism can increase susceptibility to MAFLD. Multiple parallel 'hits' have been proposed for develo...
Cameron Gofton,McCawley Clark-Dickson,Jacob George
Cameron Gofton
Since the nomenclature change from nonalcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD), much work has been undertaken to establish the clinical characteristics as well as the hepatic and extrahepatic...
Carolyn Vespoli,Anoop Mohamed Iqbal,Mohammad Nasser Kabbany et al.
Carolyn Vespoli et al.
Metabolic-associated fatty liver disease (MAFLD) has become the most common cause for chronic liver disease among children and adolescents globally. Although liver biopsy remains the gold standard for diagnosis, emerging technology, like ve...
Sherouk Fouda,Mohammed Sadiq Jeeyavudeen,Joseph M Pappachan et al.
Sherouk Fouda et al.
Metabolic-associated fatty liver disease (MAFLD), formerly known as nonalcoholic fatty liver disease, is highly associated with the metabolic syndrome. Given its high heterogeneity in patients along with unpredictable clinical outcomes, MAF...
Rita Rastogi Kalyani
Rita Rastogi Kalyani